[Skip to Content]
[Skip to Content Landing]
Invited Commentary
May 2018

The Reality of Long-term Follow-up of Bariatric/Metabolic Surgery Patients—A Conundrum

Author Affiliations
  • 1Fresno Medical Education Program, University of California San Francisco, Fresno
  • 2Minimally Invasive and Bariatric Surgery, Fresno Heart and Surgical Hospital, Fresno, California
  • 3The European School of Laparoscopic Surgery, Brussels, Belgium
JAMA Surg. 2018;153(5):435. doi:10.1001/jamasurg.2017.5010

The frustration in advocating for universal policies and mandating insurance coverage for the treatment of patients with adiposity-based chronic disease (ie, morbid obesity) is fueled by the lack of high-quality long-term data. Are weight loss and remission of metabolic syndrome durable? Are there subsequent disease states or concerns brought on by our current interventions? The Longitudinal Assessment of Bariatric Surgery (LABS) consortium, funded by the National Institute of Diabetes and Digestive and Kidney Diseases with the assistance of the National Institutes of Health Office of Research on Women’s Health, represents the third installment of a large, extensive database with reported 82.9% of study participant follow-up at 7 years.1 Outcomes are consistent with other population-based studies, such as the Swedish Obese Subjects trial2 and Utah Obesity Study.3

×